Blog
Targeting USP22 to Boost Anticancer Immunity
Targeting USP22: A New Approach to Enhance Anticancer Immunity
Introduction
In the ever-evolving landscape of cancer research, the intricate relationship between immune evasion and tumor biology remains a focal point of investigation. The immune system, with its remarkable ability to recognize and eliminate malignant cells, is often thwarted by various mechanisms employed by tumors to evade detection. Among the myriad of proteins involved in this complex interplay, USP22 (Ubiquitin Specific Peptidase 22) has emerged as a significant player. This deubiquitinating enzyme is not only pivotal in regulating protein stability but also plays a crucial role in modulatin
…
1st Aug 2025